tiprankstipranks
Trending News
More News >
Anbio Biotechnology Class A (NNNN)
:NNNN
US Market
Advertisement

Anbio Biotechnology Class A (NNNN) Similar Stocks

Compare
44 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Anbio Biotechnology Class A
$30.19
$3.42B
391.75
311.44%
Merit Medical Systems
$87.20
$5.17B
44.63
-17.21%
6 Buy
1 Hold
0 Sell
Strong Buy
Repligen
$162.51
$9.15B
6,323.35
13.98%
11 Buy
4 Hold
0 Sell
Moderate Buy
Teleflex
$124.75
$4.83B
-41.86%
1 Buy
2 Hold
0 Sell
Moderate Buy
Stevanato Group
$22.38
$6.11B
39.34
14.18%
2 Buy
1 Hold
0 Sell
Moderate Buy
Bausch + Lomb Corporation
$15.07
$5.34B
-22.99%
3 Buy
8 Hold
1 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NNNN
Anbio Biotechnology Class A
23.74
18.07
318.69%
MMSI
Merit Medical Systems
87.20
-17.72
-16.89%
RGEN
Repligen
162.51
16.45
11.26%
TFX
Teleflex
110.23
-82.27
-42.74%
STVN
Stevanato Group
22.38
2.52
12.69%
BLCO
Bausch + Lomb Corporation
15.07
-4.60
-23.39%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis